Table 5.
Prognostic performance of biomarkers and ICU scores for 30-day and 6-month all-cause mortality during the first week of ICU treatment
Presepsin | Interleukin-6 | Procalcitonin | C-reactive protein | Leukocytes | SOFA | APACHE II | |
---|---|---|---|---|---|---|---|
AUC (95% CI) | |||||||
30-day all-cause mortality | |||||||
Day 1 | 0.64 | 0.69 | 0.59 | 0.54 | 0.51 | 0.64 | 0.70 |
(0.54, 0.75) | (0.55, 0.76) | (0.48, 0.69) | (0.43, 0.65) | (0.41, 0.62) | (0.52, 0.77) | (0.60, 0.80) | |
P = 0.008 | P = 0.001 | P = 0.1 | P = 0.5 | P = 0.8 | P = 0.05 | P = 0.0001 | |
Day 3 | 0.70 | 0.69 | 0.58 | 0.64 | 0.55 | 0.65 | 0.64 |
(0.59, 0.81) | (0.58, 0.80) | (0.46, 0.70) | (0.52, 0.76) | (0.42, 0.67) | (0.53, 0.77) | (0.51, 0.77) | |
P = 0.002 | P = 0.002 | P = 0.2 | P = 0.03 | P = 0.5 | P = 0.04 | P = 0.04 | |
Day 8 | 0.69 | 0.67 | 0.57 | 0.61 | 0.60 | 0.69 | 0.60 |
(0.56, 0.82) | (0.54, 0.81) | (0.41, 0.73) | (0.46, 0.75) | (0.46, 0.75) | (0.57, 0.81) | (0.42, 0.78) | |
P = 0.02 | P = 0.03 | P = 0.4 | P = 0.2 | P = 0.2 | P = 0.007 | P = 0.3 | |
58 of 116 patients died after 30 days corresponding to a 50% all-cause mortality rate. | |||||||
6 months all-cause mortality | |||||||
Day 1 | 0.68 | 0.66 | 0.59 | 0.57 | 0.54 | 0.67 | 0.65 |
(0.58, 0.78) | (0.56, 0.76) | (0.49, 0.70) | (0.45, 0.69) | (0.43, 0.65) | (0.55, 0.78) | (0.54, 0.76) | |
P = 0.001 | P = 0.05 | P = 0.1 | P = 0.2 | P = 0.5 | P = 0.01 | P = 0.01 | |
Day 3 | 0.70 | 0.70 | 0.57 | 0.61 | 0.59 | 0.64 | 0.61 |
(0.59, 0.80) | (0.59, 0.80) | (0.45, 0.69) | (0.49, 0.73) | (0.47, 0.71) | (0.52, 0.76) | (0.48, 0.74) | |
P = 0.002 | P = 0.001 | P = 0.3 | P = 0.08 | P = 0.2 | P = 0.04 | P = 0.1 | |
Day 8 | 0.71 | 0.67 | 0.56 | 0.63 | 0.60 | 0.71 | 0.64 |
(0.58, 0.83) | (0.54, 0.80) | (0.42, 0.70) | (0.49, 0.77) | (0.46, 0.74) | (0.60, 0.83) | (0.44, 0.84) | |
P = 0.004 | P = 0.02 | P = 0.4 | P = 0.06 | P = 0.2 | P = 0.001 | P = 0.2 | |
72 of 116 patients died after 6 months corresponding to a 62% all-cause mortality rate. |
Significant P-values (P <0.05) are highlighted in bold type. AUC, area under the curve; APACHE II, acute physiology and chronic health evaluation II; SOFA, sequential organ failure assessment.